CNS Pharmaceuticals posts on-demand Virtual Investor “Why Now” webcast presentation
CNSP•On-demand webcast presentation posted
CNS Pharmaceuticals posted an on-demand video webcast tied to its Virtual Investor “Why Now” presentation.
Management outlined a strategic transformation driven by a new leadership team, a stronger balance sheet, and asset-screening discipline.
Discussion referenced a recent $22.5 million financing, including anticipated use of proceeds and strategy milestones.
Webcast available at https://pr.report/pli4.
